L. Guenther, “Ixekizumab Results in Persistent Clinical Improvement in Moderate-to-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial”, Acta Derm Venereol, vol. 100, no. 1, pp. 1–9, Jan. 2020.